Ventana Biotech Stock Cash And Equivalents
| VNTA Stock | USD 0.0004 0.00 0.00% |
Ventana Biotech fundamentals help investors to digest information that contributes to Ventana Biotech's financial success or failures. It also enables traders to predict the movement of Ventana Pink Sheet. The fundamental analysis module provides a way to measure Ventana Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventana Biotech pink sheet.
Ventana |
Ventana Biotech Company Cash And Equivalents Analysis
Ventana Biotech's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Ventana Biotech has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
Ventana Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventana Biotech's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ventana Biotech could also be used in its relative valuation, which is a method of valuing Ventana Biotech by comparing valuation metrics of similar companies.Ventana Biotech is currently under evaluation in cash and equivalents category among its peers.
Ventana Fundamentals
| Current Valuation | 165.2 K | |||
| Shares Outstanding | 55.07 M | |||
| Price To Earning | (1.00) X | |||
| Gross Profit | (260) | |||
| EBITDA | (36.71 K) | |||
| Net Income | (47.08 K) | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (54.01 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | -2.08 | |||
| Market Capitalization | 192.73 K |
About Ventana Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventana Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventana Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventana Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ventana Pink Sheet
Ventana Biotech financial ratios help investors to determine whether Ventana Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ventana with respect to the benefits of owning Ventana Biotech security.